L. Feray, M. P. Bertrand
FULL PAPER
(dsept., J = 10.0, 6.6 Hz, 1 H), 5.17–5.29 (m, 2 H), 5.73 (dd, J = 1.5,
1 H), 6.27 (dd, J = 1.9, 10.6 Hz, 1 H) ppm. 13C NMR (75 MHz,
10.2 Hz, 1 H), 5.66–5.85 (superimposed m, 1 H) ppm. 13C NMR CDCl3): δ = 21.7 (t, JC,D = 19.8 Hz, CH2), 22.8 (CH3), 23.1 (CH3),
(75 MHz, CDCl3): δ = 11.8 (CH2), 23.0 (CH3), 23.3 (CH3), 25.8 28.6 (CH), 29.0 (CH), 46.0 (CH2), 52.7 (CH2), 118.2 (CH2), 132.9
(CH), 39.1 (CH), 45.7 (CH2), 51.4 (CH2), 118.8 (CH2), 131.2 (C),
132.6 (CH), 147.1 (CH), 167.5 (C=O) ppm. HRMS: calcd. for
C12H18INO [M + H]+ 320.0505; found 320.0502. Data for (E)-4
(major isomer): 1H NMR (300 MHz, CDCl3): δ = 1.03 (d, J =
6.6 Hz, 3 H), 1.08 (d, J = 6.6 Hz, 3 H), 1.19 (d, J = 7.2 Hz, 3 H),
2.58 (dsept., J = 10.6, 6.6 Hz, 1 H), 2.89 (dd, J = 1.9, 9.8 Hz, 1 H),
3.03 (pseudo tt, J = 1.9, 7.2 Hz, 1 H), 3.50 (dd, J = 7.7, 9.8 Hz, 1
H), 3.90 (br. dd, J = 15.2, 6.2 Hz, 1 H), 4.03 (br. dd, J = 15.2,
6.0 Hz, 1 H), 5.15–5.24 (m, 2 H), 5.74 (ddt, J = 17.4, 9.8, 6.0 Hz,
1 H), 6.27 (dd, J = 1.9, 10.6 Hz, 1 H) ppm. 13C NMR (75 MHz,
CDCl3): δ = 22.0 (CH3), 22.8 (CH3), 23.1 (CH3), 28.6 (CH), 29.0
(CH), 46.0 (CH2), 52.7 (CH2), 118.2 (CH2), 132.9 (CH), 134.8 (C),
140.6 (CH), 168.6 (C=O) ppm. HRMS: calcd. for C12H19NO [M
+ H]+ 194.1539; found 194.1536.
(CH), 134.8 (C), 140.6 (CH), 168.6 (C=O) ppm. HRMS: calcd. for
C12H18DNO [M + H]+ 195.1602; found 195.1594.
(E)-N,N-Diallylpent-2-enamide (9): 1H NMR (300 MHz, CDCl3): δ
= 1.06 (t, J = 7.4 Hz, 3 H), 2.23 (pseudo quint.d, J = 7.4, 1.3 Hz,
2 H), 3.82–4.18 (m, 4 H), 5.09–5.27 (m, 4 H), 5.66–5.89 (m, 2 H),
6.14 (dt, J = 15.9, 1.3 Hz, 1 H), 6.99 (dt, J = 15.1, 6.6 Hz, 1 H)
ppm. 13C NMR (75 MHz, CDCl3): δ = 13.0 (CH3), 26.0 (CH2),
48.8 (CH2), 49.5 (CH2), 117.0 (CH2), 117.6 (CH2), 119.7 (CH),
133.5 (CH), 133.8 (CH), 148.8 (CH), 167.3 (C=O) ppm. HRMS:
calcd. for C11H17NO [M + H]+ 180.1382; found 180.1378.
(E)-N,N-Diallyl-4-methylpent-2-enamide (10): 1H NMR (300 MHz,
CDCl3): characteristic signals: δ = 2.40 (oct.d, J = 6.8, 1.1 Hz, 1
H), 6.05 (dd, J = 15.1, 1.1 Hz, 1 H), 6.84 (dd, J = 15.1, 6.8 Hz, 1
H) ppm.
General Procedure for the Reaction of Dialkylzinc Reagents with
Amide 1: The mediator (R2Zn or Et3B) was added under an atmo-
sphere of argon at room temperature to a 0.2- solution of sub-
strate in dichloromethane. The reaction was stirred at the same
temperature whilst air (20 mL) was injected through a needle into
the solution for 1 h. After stirring for 6 h at room temperature, the
reaction was quenched by adding aqueous NH4Cl, D2O or ND4Cl.
The reaction mixture was extracted with CH2Cl2 (ϫ3). The organic
layer was dried, filtered and concentrated. The crude product was
purified by FC on silica gel (see Table 2).
Deuterated Compound 5: 1H NMR (300 MHz, CDCl3): δ = 4.00
(br. d, J = 6.0 Hz, 2 H), 4.16 (br. d, J = 5.7 Hz, 2 H), 5.11–5.27
(m, 4 H), 5.65–5.85 (m, 2 H) ppm. 13C NMR (75 MHz, CDCl3): δ
= 46.7 (CH2), 50.9 (CH2), 76.1 (t, J = 7.7 Hz, CC-D), 79.3 (t, J =
39.0 Hz, C-D), 118.6 (CH2), 118.7 (CH2), 132.2 (CH), 132.8 (CH),
153.6 (C=O) ppm. HRMS: calcd. for C9H10DNO [M + H]+
151.0976; found 151.0973.
1-Allyl-4-methyl-3-propylidenepyrrolidin-2-one (6): 1H NMR
(300 MHz, CDCl3): δ = 1.08 (t, J = 7.6 Hz, 3 H), 1.18 (d, J =
7.0 Hz, 3 H), 2.21 (pseudo quint., J = 7.6 Hz, 2 H), 2.90 (dd, J =
1.9, 9.6 Hz, 1 H), 2.97–3.09 (m, 1 H), 3.50 (dd, J = 7.9, 9.6 Hz, 1
H), 3.90 (br. dd, J = 6.0, 15.1 Hz, 1 H), 4.04 (br. dd, J = 5.9,
15.1 Hz, 1 H), 5.11–5.25 (m, 2 H), 5.75 (ddt, J = 9.6, 17.4, 6.0 Hz,
1 H), 6.43 (dt, J = 2.1, 7.7 Hz, 1 H) ppm. 13C NMR (75 MHz,
CDCl3): δ = 14.0 (CH3), 21.5 (CH3), 22.3 (CH2), 29.0 (CH), 45.9
(CH2), 52.6 (CH2), 118.2 (CH2), 132.9 (CH), 135.5 (CH), 136.6 (C),
168.4 (C=O) ppm. HRMS: calcd. for C11H17NO [M + H]+
180.1382; found 180.1382.
General Procedure for the Reaction of Dialkylzinc Reagents and
Alkyl Iodides with Ester 11: Alkyl iodide (10 equiv.) was added un-
der an atmosphere of argon at room temperature to a 0.2- solu-
tion of substrate 11 in dichloromethane. The mediator (R2Zn or
Et3B) was then introduced, and the reaction was stirred at the same
temperature whilst air (20 mL) was injected through a needle into
the solution for 1 h. After stirring for 6 h, the reaction was
quenched by adding aqueous NH4Cl. The reaction mixture was
extracted with CH2Cl2 (ϫ3). The organic layer was dried, filtered
and concentrated. The crude product was purified by FC on silica
gel (see Table 3).
Allyl Propynoate (11): Substrate 11 was prepared according to a
known procedure.[28] To a solution of propiolic acid (4 mL,
64.87 mmol) in DMF (25 mL) was added NaHCO3 (10.9 g,
129.74 mmol, 2 equiv.) portionwise. After 1 h stirring at room tem-
perature, allyl bromide (8.4 mL, 97.3 mmol, 1.5 equiv.) was added,
and the reaction was stirred for one night. The reaction was diluted
with Et2O (25 mL) and washed several times with water. The or-
ganic layer was dried (MgSO4), filtered and concentrated in vacuo.
Compound 11 was isolated in 97% yield (6.9 g, 63.21 mmol).1H
NMR (300 MHz, CDCl3): δ = 2.91 (s, 1 H), 4.70 (br. d, J = 5.8 Hz,
2 H), 5.31 (br. dd, J = 10.4, 1.0 Hz, 1 H), 5.39 (br. dd, J = 17.1,
1.0 Hz, 1 H), 5.94 (ddt, J = 17.1, 10.4, 5.8 Hz, 1 H) ppm. 13C
NMR (75 MHz, CDCl3): δ = 67.1 (CH2), 74.9 (CH), 75.4 (C), 119.9
(CH2), 131.2 (CH), 152.7 (C=O) ppm.
(E)-Allyl 4,4-Dimethylpent-2-enoate (12) and Allyl 2-Iodo-4,4-di-
methylpent-2-enoate (15): Treatment of 11 (100 mg, 0.91 mmol) ac-
cording to the general procedure in the presence of tert-butyl iodide
(1.1 mL, 9.1 mmol, 10 equiv.) and diethylzinc (1.4 mL, 1.4 mmol,
1.5 equiv.) led to 12 (136 mg, 0.808 mmol, 89%) after FC (2–10%
Deuterated Compound 7: 1H NMR (300 MHz, CDCl3): δ = 1.08 (t,
J = 7.6 Hz, 3 H), 1.14–1.21 (m, 2 H), 2.21 (pseudo quint., J =
7.6 Hz, 2 H), 2.90 (dd, J = 1.9, 9.6 Hz, 1 H), 2.97–3.09 (m, 1 H),
3.50 (dd, J = 7.9, 9.6 Hz, 1 H), 3.90 (br. dd, J = 6.0, 15.1 Hz, 1 H),
4.04 (br. dd, J = 5.9, 15.1 Hz, 1 H), 5.11–5.25 (m, 2 H), 5.75 (ddt,
J = 9.6, 17.4, 6.0 Hz, 1 H), 6.43 (dt, J = 2.1, 7.7 Hz, 1 H) ppm.
1
AcOEt/pentane). A trace amount of 15 was detected by H NMR
spectroscopic analysis of the crude reaction mixture. Treatment of
11 (100 mg, 0.91 mmol) according to the general procedure in the
presence of tert-butyl iodide (1.1 mL, 9.1 mmol, 10 equiv.) and di-
ethylzinc (0.36 mL, 0.364 mmol, 0.4 equiv. in 2 portions, 0.2 equiv.
every 2 h) led to 12 (31 mg, 0.184 mmol, 20%) and 15 (141 mg,
0.478 mmol, 53%) after FC (2–10% AcOEt/pentane). Treatment of
11 (100 mg, 0.91 mmol) according to the general procedure in the
presence of tert-butyl iodide (1.1 mL, 9.1 mmol, 10 equiv.) and di-
ethylzinc (0.18 mL, 0.182 mmol, 0.2 equiv., 2ϫ0.1 equiv. every 2 h)
13C NMR (75 MHz, CDCl3): δ = 14.0 (CH3), 21.5 (t, JC,D
=
19.8 Hz, CH2), 22.3 (CH2), 29.0 (CH), 45.9 (CH2), 52.6 (CH2),
118.2 (CH2), 132.9 (CH), 135.5 (CH), 136.6 (C), 168.4 (C=O) ppm.
HRMS: calcd. for C11H16DNO [M + H]+ 181.1446; found
181.1442.
Deuterated Compound 8: 1H NMR (300 MHz, CDCl3): δ = 1.03 (d,
J = 6.6 Hz, 3 H), 1.08 (d, J = 6.6 Hz, 3 H), 1.13–1.20 (m, 2 H), led to 12 (16 mg, 0.094 mmol, 10%) and 15 (184 mg, 0.626 mmol,
2.58 (dsept., J = 10.6, 6.6 Hz, 1 H), 2.89 (dd, J = 1.9, 9.8 Hz, 1 H),
3.03 (pseudo tt, J = 1.9, 7.2 Hz, 1 H), 3.50 (dd, J = 7.7, 9.8 Hz, 1
H), 3.90 (br. dd, J = 15.2, 6.2 Hz, 1 H), 4.03 (br. dd, J = 15.2,
69%) after FC (2–10% AcOEt/pentane). Data for 12: 1H NMR
(300 MHz, CDCl3): δ = 1.07 (s, 9 H), 4.62 (dt, J = 5.6, 1.3 Hz, 2
H), 5.20–5.39 (m, 2 H), 5.76 (d, J = 15.9 Hz, 1 H), 5.95 (ddt, J =
6.0 Hz, 1 H), 5.15–5.24 (m, 2 H), 5.74 (ddt, J = 17.4, 9.8, 6.0 Hz, 17.2, 10.4, 5.7 Hz, 1 H), 6.99 (d, J = 15.9 Hz, 1 H) ppm. 13C NMR
3168
www.eurjoc.org
© 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2008, 3164–3170